Overall, our study not only revealed the pivotal role of ITGB4 and its Y1510 phosphorylation in the tumorigenesis of pancreatic cancer but it also provided a rationale for targeting ITGB4 or its Y1510 phosphorylation, as a novel therapeutic option for pancreatic cancer. The gene discussed is ITGB4; the disease is pancreatic neoplasm.